» Authors » Per-Henrik Groop

Per-Henrik Groop

Explore the profile of Per-Henrik Groop including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 380
Citations 8379
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmenkari H, Adeshara K, Pirttiniemi A, Linden J, Lehtonen S, Sandholm N, et al.
Physiol Rep . 2025 Feb; 13(5):e70161. PMID: 40018982
Inflammatory molecules originating from an inflamed gut can promote systemic inflammation. We studied how acute intestinal injury affects the kidneys and the kallikrein-kinin system in mice with dextran sodium sulfate...
2.
Claesson T, Mutter S, Putaala J, Salli E, Gordin D, Groop P, et al.
BMC Endocr Disord . 2025 Feb; 25(1):43. PMID: 39966749
Introduction: Type 1 diabetes is suspected to hamper brain growth, implying that people with earlier diabetes onset would, on average, achieve lower maximal brain volume. We set out to test...
3.
Seppala M, Lukander H, Waden J, Eriksson M, Harjutsalo V, Groop P, et al.
Cardiovasc Diabetol . 2025 Jan; 24(1):24. PMID: 39827099
No abstract available.
4.
Valo E, Richmond A, Mutter S, Dahlstrom E, Campbell A, Porteous D, et al.
Nat Commun . 2025 Jan; 16(1):325. PMID: 39746953
Dissecting the genetic mechanisms underlying urinary metabolite concentrations can provide molecular insights into kidney function and open possibilities for causal assessment of urinary metabolites with risk factors and disease outcomes....
5.
Syreeni A, Dahlstrom E, Smyth L, Hill C, Mutter S, Gupta Y, et al.
medRxiv . 2024 Dec; PMID: 39649605
Background: DNA methylation differences are associated with kidney function and diabetic kidney disease (DKD), but prospective studies are scarce. Therefore, we aimed to study DNA methylation in a prospective setting...
6.
Antikainen A, Mutter S, Harjutsalo V, Thorn L, Groop P, Sandholm N
Cardiovasc Diabetol . 2024 Nov; 23(1):425. PMID: 39593124
Background: Type 1 diabetes increases the risk of coronary artery disease (CAD). High-throughput metabolomics may be utilized to identify metabolites associated with disease, thus, providing insight into disease pathophysiology, and...
7.
Seppala M, Lukander H, Waden J, Eriksson M, Harjutsalo V, Groop P, et al.
Cardiovasc Diabetol . 2024 Oct; 23(1):387. PMID: 39472875
Background: Sedentary behavior, such as excessive sitting, increases risk of cardiovascular disease and premature mortality in the general population, but this has not been assessed in type 1 diabetes. Occupational...
8.
Stougaard E, Tougaard N, Sivalingam S, Hansen C, Storling J, Hansen T, et al.
J Diabetes Complications . 2024 Oct; 38(12):108892. PMID: 39471704
Aims: To estimate whether a mix of pre- and probiotics would strengthen the gut barrier and protect the kidneys in individuals with type 1 diabetes and albuminuria. Methods: Randomized, placebo-controlled,...
9.
Kennedy C, Doyle R, Gough O, Mcevoy C, Anallen S, McAnallen S, et al.
Kidney360 . 2024 Oct; 5(12):1799-1812. PMID: 39450948
No abstract available.
10.
Adeshara K, Di Marco E, Bordino M, Gordin D, Bernardi L, Cooper M, et al.
Cardiovasc Diabetol . 2024 Sep; 23(1):350. PMID: 39342285
Background: Hyperglycemia-induced oxidative stress is a well-established pathological mediator of vascular complications in diabetes. We assessed plasma oxidant and antioxidant levels in response to acute and chronic hyperglycemia in relation...